HUYA, TIPR announce medical innovation JV
China | News | By BioSpectrum Bureau | 0 Comment | 15 Sep, 2014
Singapore: In a bid to develop medical innovation for global markets, industry leaders, HUYA Bioscience International an...Read more
WuXi CRO gets toxicity prediction software license
China | News | By BioSpectrum Bureau | 0 Comment | 13 Nov, 2013
Singapore: WuXi PharmaTech, a China-based contract research organization (CRO), has obtained a multiyear license to Adme...Read more
Waters UPLC I-Class System approved in China
China | News | By BioSpectrum Bureau | 0 Comment | 17 Apr, 2015
Singapore: The Chinese food and drug administration has approved the usage of Waters' ACQUITY UPLC I- Class IVD/Xevo TQ...Read more
China to export macrolide antibiotic to India
China | News | By BioSpectrum Bureau | 0 Comment | 10 Sep, 2014
Singapore: China-based Tianyin Pharmaceutical's API operation Jiangchuan Macrolide Facility has initiated the applicatio...Read more
Leukemia cluster among iPhone 6 workers
China | News | By BioSpectrum Bureau | 0 Comment | 16 Sep, 2014
Singapore: Apple had recently announced that pre-orders for iPhone 6 smartphones reached 4 million within 24 hours. But,...Read more
Israel firm to develop epilepsy drug in China
China | News | By BioSpectrum Bureau | 0 Comment | 15 Apr, 2015
Singapore: Chinese Food and Drug Administration (CFDA) has approved Israel based D-Pharm to conduct clinical development...Read more
Bayer completes acquisition of Chinese pharmaceutical firm
China | News | By BioSpectrum Bureau | 0 Comment | 05 Nov, 2014
Singapore: Bayer has completed the acquisition of Dihon Pharmaceutical Group Co Ltd., Kunming, Yunnan, China. This is B...Read more
China frames a policy for hospital drug purchases
China | News | By BioSpectrum Bureau | 0 Comment | 02 Mar, 2015
Singapore: The Chinese health ministry has recently issued an policy stating that hospitals must purchase drugs only fro...Read more
Demand for generics in Asia is drawing pharma majors
China | Opinion | By BioSpectrum Bureau | 2 Comment | 14 Sep, 2012
The clinical trials market in the Asia Pacific (APAC) region has been steadily growing with increased focus primarily on...Read more
Merck aims to expand its China business
China | News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2014
Singapore: Leading pharma giant Merck has reinforced its commitments towards China, in a bid to strengthen its position ...Read more
China | Analysis | By BioSpectrum Bureau | 0 Comment | 24 Jun, 2015
Singapore: YUNNAN BAIYAO GROUP, ChinaChairman: Mr Yin PinyaoRevenue: $2942.4mnBusiness: Traditional Chinese Medicines...Read more
Fosun Pharma to invest in Israel's Check-Cap
China | News | By BioSpectrum Bureau | 0 Comment | 20 Oct, 2014
Singapore: China's Fosun Pharma has plans to invest in clinical development of an endoscopy capsule with a colon imaging...Read more
Pharma sector may lose $65 bn by 2019: Analyst
China | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2014
Singapore: Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 worldwide due to the pate...Read more
China Biologic to manufacture PCC at Shandong Taibang facility
China | Regulatory | By BioSpectrum Bureau | 2 Comment | 20 Oct, 2014
Singapore: China Biologic Products, China-based biopharmaceutical company, has received China Food and Drug Administrati...Read more
Edwards gets SFDA nod for heart valve
China | News | By BioSpectrum Bureau | 0 Comment | 05 Dec, 2012
Singapore: Edwards Lifesciences, the global leader in the science of heart valves and hemodynamic monitoring, received ...Read more
APAC type 2 diabetes market to touch $10.5 bn by 2020'
China | Analysis | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2015
Singapore: Type 2 diabetes treatment market in Asia-Pacific (APAC) will rise in value from an estimated $6.5 billion in ...Read more
China | Analysis | By BioSpectrum Bureau | 0 Comment | 15 May, 2015
Singapore: However, companies must reinvigorate and expand their deal-making strategies in order to become market leade...Read more
MSPEA, Sihuan to acquire JB hospital
China | News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2015
Singapore: Morgan Stanley Private Equity Asia (MSPEA) recently announced its partnership with HongKong listed Sihuan Pha...Read more